FDA Approves Unknown Drug — SUN PHARM INDS INC

SUN PHAR INDS INC announced its approval of ANDA075964 on June 19, 2002, but the absence of both brand and generic names alongside the route of administration renders the submission ineligible for market competition under the Hatch-Waxman Act. Consequently, given the record provided does not include a Drug Master File (DMF), we do not anticipate market implications or revenue-generating opportunities arising from this filing.